164 related articles for article (PubMed ID: 36559273)
21. Effect of the aniline fragment in Pt(II) and Pt(IV) complexes as anti-proliferative agents. Standard reduction potential as a more reliable parameter for Pt(IV) compounds than peak reduction potential.
Leal J; Santos L; Fernández-Aroca DM; Cuevas JV; Martínez MA; Massaguer A; Jalón FA; Ruiz-Hidalgo MJ; Sánchez-Prieto R; Rodríguez AM; Castañeda G; Durá G; Carrión MC; Barrabés S; Manzano BR
J Inorg Biochem; 2021 May; 218():111403. PubMed ID: 33730639
[TBL] [Abstract][Full Text] [Related]
22. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
23. Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1
Papadia P; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
Dalton Trans; 2021 Nov; 50(43):15655-15668. PubMed ID: 34673864
[TBL] [Abstract][Full Text] [Related]
24. Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study.
Ratzon E; Najajreh Y; Salem R; Khamaisie H; Ruthardt M; Mahajna J
BMC Cancer; 2016 Feb; 16():140. PubMed ID: 26906901
[TBL] [Abstract][Full Text] [Related]
25. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
Yoshida M; Khokhar AR; Siddik ZH
Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
[TBL] [Abstract][Full Text] [Related]
26. The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand (review).
Chaney S
Int J Oncol; 1995 Jun; 6(6):1291-305. PubMed ID: 21556672
[TBL] [Abstract][Full Text] [Related]
27. The antimicrobial properties of some copper(II) and platinum(II) 1,10-phenanthroline complexes.
Ng NS; Leverett P; Hibbs DE; Yang Q; Bulanadi JC; Wu MJ; Aldrich-Wright JR
Dalton Trans; 2013 Mar; 42(9):3196-209. PubMed ID: 23233164
[TBL] [Abstract][Full Text] [Related]
28. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional platinum(IV) complex bearing HDAC inhibitor and biotin moiety exhibits prominent cytotoxicity and tumor-targeting ability.
Han W; He W; Song Y; Zhao J; Song Z; Shan Y; Hua W; Sun Y
Dalton Trans; 2022 May; 51(18):7343-7351. PubMed ID: 35466968
[TBL] [Abstract][Full Text] [Related]
30. Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator.
Moretto J; Chauffert B; Ghiringhelli F; Aldrich-Wright JR; Bouyer F
Invest New Drugs; 2011 Dec; 29(6):1164-76. PubMed ID: 20535526
[TBL] [Abstract][Full Text] [Related]
31. Pt(IV) Prodrugs with Non-Steroidal Anti-inflammatory Drugs in the Axial Position.
Spector DV; Pavlov KG; Akasov RA; Vaneev AN; Erofeev AS; Gorelkin PV; Nikitina VN; Lopatukhina EV; Semkina AS; Vlasova KY; Skvortsov DA; Roznyatovsky VA; Ul'yanovskiy NV; Pikovskoi II; Sypalov SA; Garanina AS; Vodopyanov SS; Abakumov MA; Volodina YL; Markova AA; Petrova AS; Mazur DM; Sakharov DA; Zyk NV; Beloglazkina EK; Majouga AG; Krasnovskaya OO
J Med Chem; 2022 Jun; 65(12):8227-8244. PubMed ID: 35675651
[TBL] [Abstract][Full Text] [Related]
32. Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.
Ravera M; Gabano E; Zanellato I; Fregonese F; Pelosi G; Platts JA; Osella D
Dalton Trans; 2016 Mar; 45(12):5300-9. PubMed ID: 26903367
[TBL] [Abstract][Full Text] [Related]
33. Combining the platinum(ii) drug candidate kiteplatin with 1,10-phenanthroline analogues.
Pages BJ; Sakoff J; Gilbert J; Zhang Y; Kelly SM; Hoeschele JD; Aldrich-Wright JR
Dalton Trans; 2018 Feb; 47(7):2156-2163. PubMed ID: 29192713
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization and in vitro and in vivo anticancer activity of Pt(iv) derivatives of [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)].
Harper BWJ; Petruzzella E; Sirota R; Faccioli FF; Aldrich-Wright JR; Gandin V; Gibson D
Dalton Trans; 2017 May; 46(21):7005-7019. PubMed ID: 28513693
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, antiproliferative activity in cancer cells and DNA interaction studies of [Pt(cis-1,3-diaminocycloalkane)Cl
Hoeschele JD; Kasparkova J; Kostrhunova H; Novakova O; Pracharova J; Pineau P; Brabec V
J Biol Inorg Chem; 2020 Sep; 25(6):913-924. PubMed ID: 32851480
[TBL] [Abstract][Full Text] [Related]
36. Novel Pt(IV) Prodrugs Displaying Antimitochondrial Effects.
Tabrizi L; Thompson K; Mnich K; Chintha C; Gorman AM; Morrison L; Luessing J; Lowndes NF; Dockery P; Samali A; Erxleben A
Mol Pharm; 2020 Aug; 17(8):3009-3023. PubMed ID: 32628022
[TBL] [Abstract][Full Text] [Related]
37. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
Hajipour F; Mahdavinia M; Fereidoonnezhad M
Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
[TBL] [Abstract][Full Text] [Related]
38. The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators.
Kemp S; Wheate NJ; Buck DP; Nikac M; Collins JG; Aldrich-Wright JR
J Inorg Biochem; 2007 Jul; 101(7):1049-58. PubMed ID: 17544512
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity-boosting of kiteplatin by Pt(IV) prodrugs with axial benzoate ligands.
Margiotta N; Savino S; Marzano C; Pacifico C; Hoeschele JD; Gandin V; Natile G
J Inorg Biochem; 2016 Jul; 160():85-93. PubMed ID: 26775068
[TBL] [Abstract][Full Text] [Related]
40. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
